Atlas Trials

Effect of Tivantinib on the QTC Interval in Cancer Subjects

Clinical trial NCT01699061 · COMPLETED

Trial details

NCT number
NCT01699061
Sponsor
Daiichi Sankyo
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Solid Tumors
Start date
2012-07-01
Primary completion
2013-01-01
Enrollment
38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.